(Q53939721)

22 May 2018

title

CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants. (English)

1 reference

22 May 2018

main subject

lymphoblastic leukemia

1 reference

4

Fatih M Uckun

1 reference

22 May 2018

author name string

Carla M Wood

series ordinal

1

1 reference

22 May 2018

Patricia A Goodman

series ordinal

2

1 reference

22 May 2018

Alexei O Vassilev

series ordinal

3

1 reference

22 May 2018

publication date

1 March 2003

1 reference

22 May 2018

European Journal of Haematology

published in

1 reference

22 May 2018

volume

70

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

156-171

1 reference

22 May 2018

Death and anti-death: tumour resistance to apoptosis

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

CD95's deadly mission in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Cytotoxic drugs and the CD95 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Pathological findings in human autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Fas gene mutation in the progression of adult T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Mutations in the Fas antigen gene in lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Stimulation of Src family protein-tyrosine kinases as a proximal and mandatory step for SYK kinase-dependent phospholipase Cgamma2 activation in lymphoma B cells exposed to low energy electromagnetic fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Alternative splicing and programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Unfavorable prognosis of acute leukemia in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

Apoptosis. Mitochondria--the death signal integrators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

The Fas pathway in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Soluble Fas Apo-1 splicing variants and apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Acute lymphoblastic leukemia in infants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Immunobiologic differences between normal and leukemic human B-cell precursors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

Initial sequencing and analysis of the human genome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00024.X

7 January 2021

10.1034/J.1600-0609.2003.00024.X

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018